Frequencies of certain complement protein alleles and serum levels of anti-heat-shock protein antibodies in cerebrovascular diseases

Citation
J. Kramer et al., Frequencies of certain complement protein alleles and serum levels of anti-heat-shock protein antibodies in cerebrovascular diseases, STROKE, 31(11), 2000, pp. 2648-2652
Citations number
31
Categorie Soggetti
Neurology,"Cardiovascular & Hematology Research
Journal title
STROKE
ISSN journal
00392499 → ACNP
Volume
31
Issue
11
Year of publication
2000
Pages
2648 - 2652
Database
ISI
SICI code
0039-2499(200011)31:11<2648:FOCCPA>2.0.ZU;2-4
Abstract
Background and Purpose-A strong correlation exists between the intensity of atherosclerotic alterations in different arteries. Marked differences exis t, however, in the age and sex distribution and risk factors for coronary h eart disease (CHD) and cerebrovascular disease (CVD). We therefore performe d genetic and immunologic studies in patients with CVD. Methods-We studied 292 patients with CVD (stroke or transient ischemic atta ck) and as control either 198 healthy blood donors and 485 healthy elderly (aged >60 years) people (genetic study) or 94 blood donors aged 45 to 60 ye ars and 49 healthy elderly (aged >60 years) people (anti-heat-shock protein [hsp] measurements). Allele frequencies of 3 genes (C4A, C4B, and C3) enco ding proteins of the complement system were determined by electrophoresis a nd immunofixation. Serum concentration of autoantibodies against 60-kDa hea t-shock protein (anti-hsp60) was measured by the enzyme-linked immunosorben t assay method. Results-Marked differences were observed between CVD patients and controls in the genetic studies. In the CVD patients aged >60 years, the frequency ( 11.3%) of the deficient allele of the C4B gene (C4B*Q0) was significantly ( P=0.0003) higher than that of the healthy controls (5.4%). By contrast, in the group aged 45 to 60 years, the frequency of the C4B*Q0 allele was lower in patients than in controls. Serum concentration of anti-hsp60 in the CVD patients did not differ from control values. Conclusions-In previous studies C4B*Q0 frequency was reported to be higher in CHD patients aged 45 to 60 years than in aged-matched controls. Moreover , high anti-hsp60 levels were found in CHD patients. These findings contras t with our present report of lower frequency of C4B*Q0 in CVD patients. The refore, genetic and immunologic factors may at least partly explain the dif ferences between the natural history and risk factors of CHD and CVD.